Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICE Group is a leading global manufacturer of specialty chemicals and active pharmaceutical ingredients (APIs), specializing in bile acid derivatives. Headquartered in Italy, the company is the world's largest producer of Ursodeoxycholic Acid (UDCA), used to treat various liver and gallstone conditions. ICE Group operates a vertically integrated supply chain, collecting bovine bile globally to ensure a stable supply for its manufacturing facilities. In addition to its core API business, the company provides CDMO services for complex small molecule synthesis and purification. Since its acquisition by Advent International in 2019, ICE Group has continued to expand its global footprint and product portfolio within the gastroenterology and hepatology markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICE GROUP.